Inhibition of advanced glycation end products formation by stilbene and phenanthrene derivatives from prosthechea michuacana in vitro and in vivo

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

In our previous study, we isolated from chloroform extract of the bulbs of orchid P. michuacana, three antioxidant compounds: two stilbene α-α'-dihydro, 3',5',2-trimethoxy-3-hydroxy-4-acetyl-4'-isopentenyl stilbene, 5-[2-(3-hydroxy-5-methoxyphenyl)ethyl]-2-methoxyphenol (gigantol) and one phenanthrene 4,6,7-trihydroxy-2-methoxy-8-(methylbut-2-enylphenanthren-1-1'-4',6',7'-trihydroxy-2'-methoxy-8'-(methylbut-2'-enyl)-phenanthrene. Following the study, we investigated the ability of isolated compounds to inhibit advanced glycation in vitro. Bovine serum albumin was glycated in the presence of glucose or methylglyoxal. Amadori-rich protein was prepared by dialyzing lysozyme that had been glycated by ribose. We also evaluated renal function by checking formation of advanced glycation and tail tendon collagen quality in streptozotocin-induced diabetic mice. Also determined the effect on LDL and hemoglobin. Compounds can efficiently inhibit the formation of AGEs by trapping reactive methylglyoxal and showed potent anti-Amadorin activity. Also exhibited a significant inhibitory activity on the glycated hemoglobin (GHb and HbA1c). Compounds showed a protective renal effect and reduction in mice tail tendon collagen. Also the tested compounds are potent agents for protecting LDL against oxidation and glycation. We concluded that compounds from P. michuacana are potent antiglycation agents, which can be of great value in the prevention of diabetic glycation-associated-pathogenesis. © 2013 Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas.
Original languageAmerican English
Pages (from-to)69-80
Number of pages60
JournalBoletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas
StatePublished - 6 Feb 2013
Externally publishedYes

    Fingerprint

Cite this